Mocravimod hydrochloride ( KRP-203 )

产品货号. M26300 CAS No. 509088-69-1

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

拼团产品询价大包装询价加入购物车

产品名称

Mocravimod hydrochloride
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

Mocravimod hydrochloride is an effecitive and orally active agonist of sphingosine 1-phosphate receptor type 1(S1PR1).
产品描述

Mocravimod hydrochloride is an effecitive and orally active agonist of sphingosine 1-phosphate receptor type 1(S1PR1). (In Vivo):In mHC-disparate rat heart allografts, Mocravimod hydrochloride(orally; 0.1 and 1 mg/kg/day; for 100 days) prolongs graft survival and attenuates chronic rejection. Mocravimod hydrochloride ameliorates atherosclerosis in LDL-R(-/-) Mice.
同义词

KRP-203
通路

Others
靶点

Other Targets
受体

gluconeogenesis
研究领域

——
适应症

——

1.Murray AF, et, al. Phenylpropanoid Glycerol Glucosides Attenuate Glucose Production in Hepatocytes. ACS Omega. 2019 Jun 19;4(6):10670-10676.

计算器

产品手册

关联产品

Silydianin

Silydianin exerts inhibition of UGT in human liver. Silydianin exerts inhibition of OATP1B1 OATP1B3 expressed in HEK293 cells. Silydianin exerts inhibition of OATP2B1 expressed in MDCK2 cells.
7-Hydroxy-3-(4-hydro...

7-Hydroxy-3-(4-hydroxybenzyl)chroman shows moderate inhibitory activity against a chymotrypsin-like activity of the proteasome.
Methyl nomilinate

Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.